- Home
- CLNN vs ORMP Comparison
CLNN vs ORMP Comparison
Compare CLNN & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLNN | ORMP |
|---|---|---|
| Founded | 2012 | 2002 |
| Country | United States | United States |
| Employees | N/A | 13 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.6M | 117.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CLNN | ORMP |
|---|---|---|
| Price | $6.16 | $2.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $32.67 | N/A |
| AVG Volume (30 Days) | ★ 314.0K | 191.7K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 838.25 |
| EPS | N/A | ★ 1.03 |
| Revenue | $214,000.00 | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $87.58 | N/A |
| P/E Ratio | ★ N/A | $2.88 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.28 | $1.82 |
| 52 Week High | $13.50 | $3.20 |
Technical Indicators
Market Signals| Indicator | CLNN | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 39.82 | 63.60 |
| Support Level | $6.04 | $2.83 |
| Resistance Level | $6.95 | $3.03 |
| Average True Range (ATR) | 0.71 | 0.14 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 31.45 | 61.12 |
Price Performance
Historical ComparisonAbout CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.